The Jury comprises several major Healthcare companies, pharmaceutical laboratories, biotechnology societies, and public institutions together with a law firm specialized in intellectual property. They will evaluate the submitted projects following these 5 criteria:
• The scientific quality of the innovation
• The quality of the team
• The strength of intellectual property
• The project feasibility
• The chances of success on the market
Presentation
Innovation Prize 2017 – Yes you can!
For 8 years, the Innovation Prize rewards project holders in the field of Healthcare (Biotech, Medtech, E-Health). Open to young start-ups (< 8 years old) and academic laboratories, this competition became a main Life Science event, involving 38 countries and 259 participants in 2016.
Stay up-to-date by following us on and
For more information, contact-us.
3 prizes will be awarded
Once the selection process over, a laureate will be chosen among each of the following technological domains related to the healthcare industry: Biotech’s Innovation Prize, Medtech’s Innovation Prize, Health NICT’s Innovation Prize.
The biotechnology market accounted for 7% of the pharmaceutical industry’s market in 2006. Today, it provides the best growth potential to the biopharmaceutical industry while modifying the landscape and issues of this sector. Whether it deals with biologic or chemical compounds, involving new mechanisms of action or being presented as an incremental evolution, biopharmaceutical innovation is carrying new hopes for diseases’ prevention and treatment. Since 2009, the Innovation Prize aims to identify and promote these discoveries in order to boost their development by supporting them along the road to success.
With more than 500 000 different medical devices, the Medtech sectorshares a common goal between its innovations: increasing the length and improving the quality of life of patients. This booming sector has been valued at $ 100 billion worldwide with a provisional annual growth of 5% until 2020. The Innovation Prize, by assessing these promising and innovative technologies, offers the opportunity and the chance to their project leaders getting a concrete feedback from expert jury members from institutional groups and private companies.
The digital revolution through both the dematerialization and the rise of numerical reshapes the healthcare sector’s landscape. With digital, this sector is experimenting deep modifications impacting relationship between laboratories, practitioners, patients and organization itself, allowing the healthcare industry to become a true partner throughout information and training. For this 9th edition, Universal Biotech chose to reward this category by including it to the Innovation Prize together with biotech and medtech projects.
Projects in 2017
Projects since 2009
Jury Members in 2017
Countries
Therapeutic Areas
Laureates
Applications submitted in the categories of Biotech, Medtech, and Digitech will be selected after 3 evaluation rounds from May to October. Among each category, the most innovative project will be awarded during a special event on October the 9th 2017 in Pavillon Dauphine in Paris, France.
The Innovation Prize 2017 allows its participants to:
• Win up to €30 000 for each laureate including financial dotation and consulting services,
• Increase their visibility in the Life Science market field,
• Have their project evaluated by experts,
• Optimize their Business Plan.